树突状细胞和肥大细胞对肠易激综合征作用的研究进展
被引量:1
摘要
IBS以腹痛或腹部不适伴有排便异常为主要症状,是临床常见的胃肠功能紊乱性疾病。IBS在亚洲国家的发病率为6.5%~10.1%,且呈上升趋势。1BS并非单纯的功能性胃肠病,内脏高敏感和肠道动力异常是IBS两大基本病理生理变化,潜在的机制涉及肠道免疫异常激活、肠黏膜低度炎性反应、肠道菌群改变、肠黏膜屏障功能紊乱等,各机制相互关联。
出处
《中华消化杂志》
CAS
CSCD
北大核心
2015年第7期500-502,共3页
Chinese Journal of Digestion
参考文献20
-
1Lovell RM, Ford AC. Global prevalence of and risk factors forirritable bowel syndrome: a meta-analysis [ J ]. ClinGastroenterol Hepatol, 2012,10(7) :712-721. e4.
-
2Chang JY,Locke GR 3rd,McNally MA, et al. Impact offunctional gastrointestinal disorders on survival in thecommunity [J]. Am J Gastroenterol* 2010,105(4):822-832.
-
3Ohman L, Simren M. Pathogenesis of IBS: role ofinflammation, immunity and neuroimmune interactions [J].Nat Rev Gastroenterol Hepatol,2010,7(3) : 163-173.
-
4Hughes PA, Zola H, Penttila IA, et al. Immune activation inirritable bowel syndrome: can neuroimmune interactionsexplain symptoms? [J]. Am J Gastroenterol,2013, 108 ( 7):1066-1074.
-
5Cremon C, Gargano L,Morselli-Labate AM, et al. Mucosalimmune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms[J]. Am JGastroenterol, 2009,104(2) :392-400.
-
6Martinez C,Gonzalez-Castro A, Vicario M,et al. Cellular andmolecular basis of intestinal barrier dysfunction in the irritablebowel syndrome[J]. Gut Liver, 2012,6(3) :305-315.
-
7Chang L,Adeyemo M,Karagiannides I, et al. Serum andcolonic mucosal immune markers in irritable bowel syndrome[J]. Am J Gastroenterol, 2012,107(2) :262*272.
-
8Gwee KA. Post-infectious irritable bowel syndrome* aninflammation-immunological model with relevance for other IBSand functional dyspepsia [J] Neurogastroenterol Motil,2010,16(1) : 30-34.
-
9McKernan DP,Gaszner G,Quigley EM, et al. Altered peripheraltoll-like receptor responses in the irritable bowel syndrome [J].Aliment Pharmacol Ther, 2011 ?33(9): 1045-1052.
-
10Klooker TK,Braak B, Koopman KE, et al. The mast cellstabiliser ketotifen decreases visceral hypersensitivity andimproves intestinal symptoms in patients with irritable bowelsyndrome [J]. Gut, 2010,59(9) : 1213-1221.
二级参考文献23
-
1李延青,张海燕,左秀丽,袁海鹏,卢雪峰,李君曼.肠易激综合征患者肠黏膜Th1/Th2漂移的研究[J].中华消化杂志,2004,24(12):728-731. 被引量:74
-
2Chang FY, l,u CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil, 2010, 16:389-400.
-
3Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol, 2009, 104:392-400.
-
4Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritabIe bowel syndrome. Gastroenterology, 2007, 132 : 913-920.
-
5Kindt S, Van Oudenhove L, Broekaert D, et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil, 2009, 21 : 389-398.
-
6Plourde V, St-Pierre S, Quirion R. Calcitonin gene-related peptide in viscerosensitive response to colorectal distension in rats. Am J Physiol,1997, 273(1Pt1 ) : G191-G196.
-
7Agostini S, Goubern M, Tondereau V, et al. A marketed fermented dairy product containing Bifidobacterium lactis CNCM 1- 2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol Motil,2012, 24 : e376-e172.
-
8A1-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology, 2000, 119: 1276-1285.
-
9Salzmann JL, Pehier-Koch F, Bloch F, et al. Mort hometric study of colonic biopsies: a new method of estimating inflammatory diseases. Lab Invest, 1989,60:847-851.
-
10Gwee A, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut, 1999, 44:400-406.
共引文献20
-
1赵继梦,施茵,赵海音.腹泻型肠易激综合征发病机制及艾灸治疗概况[J].江西中医学院学报,2011,23(4):82-87. 被引量:6
-
2汪之沫,王文峰,龙艳芹,汪欢,钱伟,侯晓华.RNA干扰抑制IL-23表达对感染后内脏高敏感小鼠肠黏膜固有层DC活化Th17细胞功能的影响[J].胃肠病学,2012,17(2):101-105. 被引量:1
-
3易岑,秦元华,任一鑫,郑莉莉,崔昱.树突细胞在旋毛虫感染免疫中作用的研究进展[J].国际医学寄生虫病杂志,2013,40(5):285-290. 被引量:1
-
4王钰莹,陈东晖,郑鹏远,李付广.芳香烃受体对肠易激综合征小鼠模型Th17细胞活化的影响[J].中华微生物学和免疫学杂志,2014,34(4):299-303. 被引量:3
-
5张玲,邹多武.功能性胃肠病发病机制的研究进展[J].中华医学杂志,2014,94(22):1749-1751. 被引量:8
-
6谭玲婵,孙晓宁.肠易激综合征的肠粘膜免疫细胞研究进展[J].海南医学院学报,2014,20(10):1454-1456. 被引量:4
-
7胡敏鹂,华宏军,杨小云,陈跃华.IBS-D患者直肠乙状结肠交界黏膜MC活化及类胰蛋白酶的变化及作用研究[J].中国现代医生,2015,53(24):1-4. 被引量:4
-
8陈立,王承党.缓解期炎症性肠病患者的肠易激综合征样症状研究进展[J].国际消化病杂志,2015,35(4):238-240. 被引量:2
-
9胡玥,李蒙,吕宾,王曦,陈超英,张梦.内源性 CRF 对小鼠肠系膜淋巴结树突状细胞的生物表型的影响[J].中华微生物学和免疫学杂志,2015,35(9):678-683.
-
10李蒙,胡玥,王霄腾,吕宾,张梦,陈超英.ERK1/2通路对内脏高敏感大鼠肠道树突细胞表面MHC-Ⅱ分子表达的影响[J].中华医学杂志,2015,95(48):3930-3934. 被引量:4
同被引文献18
-
1刘新光.肠易激综合征与罗马Ⅲ诊断标准[J].胃肠病学,2006,11(12):736-738. 被引量:280
-
2王志坤,白海燕,刘启泉.刘启泉辨治腹泻型肠易激综合征经验[J].中医杂志,2010,51(5):404-404. 被引量:5
-
3肠易激综合征中西医结合诊疗共识意见[J].中国中西医结合杂志,2011,31(5):587-590. 被引量:238
-
4陈益忠.黛力新联合马来酸曲美布汀、布拉氏酵母菌散治疗肠易激综合征(腹泻型)临床观察[J].医学理论与实践,2011,24(21):2573-2574. 被引量:7
-
5陈东晖,陈海荣,刘志强,郑鹏远.利用小鼠模型研究肠道免疫功能紊乱在肠易激综合征致病机制中的作用[J].中华微生物学和免疫学杂志,2013,33(6):445-451. 被引量:8
-
6赵迎盼,王凤云,杨俭勤,苏敏,唐旭东.基于脑-肠互动异常的肠易激综合征发病机制的研究进展[J].中华医学杂志,2015,95(8):637-640. 被引量:19
-
7张俊平.马来酸曲美布丁联合双歧杆菌三联活菌肠溶胶囊治疗IBS110例疗效观察[J].中国实用医药,2015,10(11):143-144. 被引量:4
-
8方秀才.我国肠易激综合征的诊断现状[J].中华消化杂志,2015,35(7):438-440. 被引量:17
-
9刘劲松.从循证医学证据看肠易激综合征的常规药物治疗[J].中华消化杂志,2015,35(7):441-443. 被引量:6
-
10胡敏鹂,华宏军,杨小云,陈跃华.IBS-D患者直肠乙状结肠交界黏膜MC活化及类胰蛋白酶的变化及作用研究[J].中国现代医生,2015,53(24):1-4. 被引量:4
-
1钟瑾,郭光丽,刘亚红.肠易激综合征患者的护理[J].河北医药,2010,32(8):1015-1016. 被引量:6
-
2程云杰,杨通神,刘胜.自拟“平腹汤”治疗肠易激综合征85例疗效观察[J].中国民族民间医药,2012,21(13):108-108.
-
3李兆东,李定国.肠易激综合征的药物治疗研究进展[J].国外医学(内科学分册),2001,28(2):67-70. 被引量:6
-
4刁兴元,李志仁,李文英.思密达治疗腹泻型肠易激综合征的临床观察[J].中华腹部疾病杂志,2003,3(11):819-820.
-
5郭德忠.应激与IBS之间关系的研究进展[J].青海医药杂志,2004,34(2):60-62. 被引量:1
-
6李宇,陈学和,王福华.肠易激综合征[J].中国医刊,2003,38(9):34-36. 被引量:4
-
7李国霞,李仕平,梁广和,范红亮.疏肝健脾法对肠易激综合征患者血清NO的调节作用[J].天津中医药,2003,20(2):72-72. 被引量:7
-
8刘长娟,刘英,薛捍臣.半夏泻心汤和四神丸加减治疗腹泻型肠易激综合征60例[J].中国民间疗法,2015,23(7):43-44. 被引量:4
-
9姚树坤,肖琦凡.益生菌治疗肠易激综合征的临床研究进展[J].中华消化杂志,2013,33(12):806-808. 被引量:5
-
10王阶,吴欣芳,李勇,曾毅.HIV/AIDS免疫异常激活及其与疾病进展的相关性研究[J].中国中药杂志,2013,38(15):2429-2433. 被引量:5